Investor Information

True Leaf Launches the First Crowdfunding Campaign for Cannabis Products that are Federally Legal in the US and Canada.


true leaf investor

True Leaf is offering a Regulation A+ initial public offering, giving anyone the opportunity to invest in hemp and cannabis products that will be fully legal in both the United States and Canada.

True Leaf is using Regulation A+ to raise $10 million Canadian. The funds will be used to grow the revenue of its subsidiary True Leaf Pet, and to advance the efforts of its subsidiary True Leaf Medicine to become a licensed producer of medicinal cannabis in Canada.

In both Canada and the US, Regulation A+ makes it possible for anyone to purchase a company’s securities.

Currently, the sale of medicinal cannabis is legal in Canada, and the Canadian Government is committed to legalizing cannabis for recreational purposes in 2018. True Leaf Medicine is in the final stage of becoming a licensed producer of medicinal marijuana. The Company’s facility is on a 40-acre site in Lumby, British Columbia. The facility will have a production capacity of over 6,000 kilograms of dried cannabis per year once phase one of the project is completed.

True Leaf’s Pet division markets only legal hemp-seed based pet products online and in 1500 stores across the United States, Canada, Europe and New Zealand while it seeks a license to sell medicinal cannabis in Canada. True Leaf’s current and future products will comply with laws in every jurisdiction those products are sold. For more information on this investment...





2017 Financials



Investing in our Common Stock involves a high degree of risk. The company cannot predict the extent to which an active market for its Common Stock will develop or be sustained after this offering, or how the development of such a market might affect the market price of its common stock. Investors in this offering will experience immediate and substantial dilution and market price of the Company’s common stock may fluctuate. For a complete discussion of risks, please refer to the Form 1-A. The offering is being made only by means of an offering circular. An offering statement on Form 1-A relating to these securities has been qualified by the Securities and Exchange Commission. You may obtain a copy of the final offering circular below. This document contains forward-looking statements reflecting current expectations that involve risks and uncertainties. These forward-looking statements include statements regarding commercialization plans, projected timelines, etc. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors, including those discussed in the section entitled "Risk Factors" and elsewhere in the offering circular. This document shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No money or other consideration is being solicited in connection with this document, and if sent in response, will not be accepted. Any person's indication of interest involves no obligation or commitment of any kind.

Regulation A+ Disclaimer:

True Leaf Medicine International Ltd. is testing the waters to gauge market demand for a proposed Regulation A Tier 2 offering. No money or other consideration is being solicited, and if sent in response to any solicitation, it will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until an offering statement on Form 1-A is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance is given after the qualification date. Any person's indication of interest involves no obligation or commitment of any kind. An offering statement regarding this offering has been filed with the SEC. You may obtain a copy of the offering circular that is part of that offering statement from: You should read the offering circular before making any investment.